Request Trial
6 October 2026NewsCareersSarah Speight

Latham adds ‘exceptional’ ITC expert and 5th trial lawyer in a year

The new partner advises technology and life sciences companies in Section 337 investigations and related patent disputes, drawing on extensive private practice and government experience.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
Irish law firms announce merger
10 November 2026   Leading IP practices join forces to build a national powerhouse in Dublin and Cork, offering combined expertise in life sciences, medical technology, engineering, software, electronics, communications, and advanced manufacturing.
Careers
Dykema’s new trademark pro will be a ‘tremendous asset’ to clients
4 November 2026   Joining in Wisconsin, the senior counsel brings “sophisticated” trademark experience and leadership, and counts biotechnology among her sectors.
Careers
Fenwick hires NY partner to advise on regulatory matters
2 November 2026   New partner joins from Goodwin, where he was a life sciences partner, bringing experience in healthcare transactions, and regulatory and strategic counselling, among other areas.


Editor's picks

In-house counsel rethink patent filing strategies as costs mount
In-house counsel
In-house counsel rethink patent filing strategies as costs mount
3 November 2026

Editor's picks

In-house counsel
In-house counsel rethink patent filing strategies as costs mount
3 November 2026
Pharma
Boehringer accuses Dr Reddy’s of ‘weaponising’ plausibility
20 October 2026
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026
Pharma
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
6 October 2026
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026

More features

South Korean biotech takes aim at US medtech leader over alleged cell-washing tech theft
GSK lands 36-country injunction in Pfizer-BioNTech vaccine litigation
‘No medicine is off limits’: US Chamber of Commerce says stricter import rules may deter fakes
GSK and Moderna settle cross-border patent dispute over vaccine tech
Eli Lilly follows Novo in UK High Court bid to block ‘black-market websites’
Irish law firms announce merger
How in-house teams can get more value from external counsel
Settled expectations, the six-year rule, and developments in USPTO policy